| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |